Why Researchers Choose Immunity for High-Impact Publications
Immunity stands as a cornerstone in the field of biological biomedical sciences, particularly immunology, offering a platform for groundbreaking discoveries that shape our understanding of immune responses and related diseases. Launched in 1994 by Cell Press, an imprint of Elsevier, this journal has evolved into one of the most prestigious outlets for immunologists worldwide. Its rigorous peer-review process ensures that only the most innovative and impactful research reaches publication, making it a top choice for scientists aiming to advance their careers through high-visibility work.
The journal's scope encompasses a broad yet focused array of topics, from innate and adaptive immunity to immune regulation, autoimmunity, and immunotherapy. Researchers value Immunity for its ability to disseminate complex findings to a global audience of experts, fostering collaborations and citations that propel scientific progress. With a commitment to open science principles where applicable, Immunity supports diverse formats like original research articles, reviews, and perspectives, all while maintaining the highest standards of clarity and reproducibility.
Publishing in Immunity not only amplifies the reach of your research but also positions you within an elite community of scholars. The journal's influence extends beyond academia into clinical applications, influencing vaccine development and therapeutic strategies. For those navigating the competitive landscape of academic publishing, Immunity represents an opportunity to contribute to foundational knowledge in biological biomedical sciences.
As you consider your next submission, explore resources to enhance your academic journey. Check out biology jobs for career opportunities or academic calendar for key deadlines. Ready to submit? Visit the higher ed jobs section for related positions that align with your expertise.
Overview & History
Immunity was established in 1994 to address the growing need for a dedicated forum on immunological research. Published by Cell Press under Elsevier, it quickly gained prominence for featuring seminal papers on T-cell receptors, cytokine signaling, and immune checkpoint mechanisms. Over the decades, it has chronicled pivotal advances, including insights into COVID-19 immune responses. Today, Immunity remains at the forefront, with monthly issues that blend cutting-edge experiments and theoretical models.
Scope and Disciplines Covered
Immunity primarily covers immunology within biological biomedical sciences, extending to intersections with microbiology, oncology, and neuroscience. It welcomes studies on immune cell development, pathogen interactions, and translational applications.
| Discipline | Description |
|---|---|
| Immunology | Core focus on innate, adaptive, and regulatory immunity. |
| Autoimmunity | Mechanisms of immune dysregulation and diseases. |
| Immunotherapy | Therapeutic strategies targeting immune responses. |
| Microbial Immunology | Host-pathogen interactions and vaccine development. |
| Neuroimmunology | Immune influences on the nervous system. |
Key Journal Metrics
| Metric | Value | Year |
|---|---|---|
| Impact Factor | 43.5 | 2022 |
| CiteScore | 53.3 | 2023 |
| h5-Index | 128 | 2023 |
| Acceptance Rate | Not publicly disclosed | - |
| Time to First Decision | Approximately 4 weeks | Recent average |
Indexing and Abstracting
Immunity is indexed in major databases, ensuring wide visibility. Key services include PubMed/MEDLINE, Scopus, Web of Science (Science Citation Index Expanded), and Embase. These affiliations facilitate discoverability and metrics tracking for authors.
Publication Model and Fees
Immunity operates a hybrid model, allowing subscription access with optional open access. Article Processing Charges (APC) for gold open access are $6,120, covering production and dissemination. Subscriptions are managed through Elsevier, with institutional access widely available. Authors retain copyright under Creative Commons licenses for OA articles.
Submission Process and Guidelines
Submissions are handled via the Editorial Manager system on the journal's official site. Manuscripts must follow detailed guidelines, including structured abstracts, figure limits, and data availability statements. Pre-submission inquiries are encouraged for novel topics. Review typically involves 2-3 experts, emphasizing mechanistic depth and novelty.
Editorial Board Highlights
The editorial team, led by Editor-in-Chief Ansuman T. Satpathy, MD, PhD from Stanford University, includes experts from Harvard, Oxford, and Max Planck Institute. Their diverse backgrounds ensure balanced oversight across global immunology research.
Why Publish in Immunity?
Publishing here offers unparalleled exposure, with articles often cited thousands of times. It enhances grant applications and tenure dossiers, particularly in biological biomedical sciences. The journal's prestige attracts collaborators and media attention, amplifying real-world impact.
Comparison with Similar Journals
| Journal | Impact Factor (2022) | Publisher | Focus |
|---|---|---|---|
| Immunity | 43.5 | Elsevier (Cell Press) | Comprehensive immunology |
| Nature Immunology | 31.2 | Springer Nature | Translational and clinical immunology |
| Journal of Immunology | 5.4 | American Association of Immunologists | Broad immunological studies |
| Science Immunology | 27.3 | AAAS | Interdisciplinary immune science |
| Trends in Immunology | 19.1 | Elsevier | Review-based immunology insights |
Researcher Tips for Successful Submission
To succeed, emphasize mechanistic novelty and broad implications. Use clear visuals and adhere to word limits. Engage with recent Immunity papers for context. Consider rate my professor for mentor feedback or PhD programs in immunology. Track progress via the portal and respond promptly to revisions.